• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

低频突变循环肿瘤DNA的片段富集

Fragment Enrichment of Circulating Tumor DNA With Low-Frequency Mutations.

作者信息

Liu Xiaojun, Lang Jidong, Li Shijun, Wang Yuehua, Peng Lihong, Wang Weitao, Han Yingmin, Qi Cuixiao, Song Lei, Yang Shuangshuang, Zhang Kaixin, Zang Guoliang, Pei Hong, Lu Qingqing, Peng Yonggang, Xi Shuxue, Wang Weiwei, Yuan Dawei, Bing Pingping, Zhou Liqian, Tian Geng

机构信息

School of Computer Science, Hunan University of Technology, Zhuzhou, China.

Bioinformatics Department, Geneis (Beijing) Co. Ltd., Beijing, China.

出版信息

Front Genet. 2020 Feb 28;11:147. doi: 10.3389/fgene.2020.00147. eCollection 2020.

DOI:10.3389/fgene.2020.00147
PMID:32180799
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7059766/
Abstract

Human blood contains cell-free DNA (cfDNA), with circulating tumor-derived DNAs (ctDNAs) widely used in cancer diagnosis and treatment. However, it is still difficult to efficiently and accurately identify and distinguish specific ctDNAs from normal cfDNA in cancer patient blood samples. In this study, ctDNA fragment length distribution analysis showed that ctDNA fragments are frequently shorter than the normal cfDNAs, which is consistent with previous findings. Interestingly, the ctDNA fragment length was found to be partially associated with the mutant allele frequency, with a low mutant allele frequency (< ~0.6%) associated with a longer ctDNA fragment length when compared to normal cfDNAs. The findings of this study contribute to improving the detection of low-frequency tumor mutations.

摘要

人类血液中含有游离DNA(cfDNA),循环肿瘤来源的DNA(ctDNA)在癌症诊断和治疗中被广泛应用。然而,在癌症患者血液样本中,仍然难以高效、准确地从正常cfDNA中识别和区分特定的ctDNA。在本研究中,ctDNA片段长度分布分析表明,ctDNA片段通常比正常cfDNA短,这与先前的研究结果一致。有趣的是,发现ctDNA片段长度与突变等位基因频率部分相关,与正常cfDNA相比,低突变等位基因频率(<~0.6%)与较长的ctDNA片段长度相关。本研究结果有助于改善低频肿瘤突变的检测。

相似文献

1
Fragment Enrichment of Circulating Tumor DNA With Low-Frequency Mutations.低频突变循环肿瘤DNA的片段富集
Front Genet. 2020 Feb 28;11:147. doi: 10.3389/fgene.2020.00147. eCollection 2020.
2
Increased detection of circulating tumor DNA by short fragment enrichment.通过短片段富集提高循环肿瘤DNA的检测率。
Transl Lung Cancer Res. 2021 Mar;10(3):1501-1511. doi: 10.21037/tlcr-21-180.
3
Fragment Length of Circulating Tumor DNA.循环肿瘤DNA的片段长度
PLoS Genet. 2016 Jul 18;12(7):e1006162. doi: 10.1371/journal.pgen.1006162. eCollection 2016 Jul.
4
Enhanced detection of circulating tumor DNA by fragment size analysis.通过片段大小分析增强循环肿瘤 DNA 的检测。
Sci Transl Med. 2018 Nov 7;10(466). doi: 10.1126/scitranslmed.aat4921.
5
Variants with a low allele frequency detected in genomic DNA affect the accuracy of mutation detection in cell-free DNA by next-generation sequencing.在基因组 DNA 中检测到的低频等位基因突变会影响下一代测序技术在游离 DNA 中的突变检测准确性。
Cancer. 2018 Mar 1;124(5):1061-1069. doi: 10.1002/cncr.31152. Epub 2017 Nov 27.
6
Genomic variations in plasma cell free DNA differentiate early stage lung cancers from normal controls.血浆游离 DNA 中的基因组变异可区分早期肺癌与正常对照。
Lung Cancer. 2015 Oct;90(1):78-84. doi: 10.1016/j.lungcan.2015.07.002. Epub 2015 Jul 15.
7
Liquid biopsy in colon cancer: comparison of different circulating DNA extraction systems following absolute quantification of mutations using Intplex allele-specific PCR.结肠癌中的液体活检:使用Intplex等位基因特异性PCR对突变进行绝对定量后不同循环DNA提取系统的比较
Oncotarget. 2017 Sep 21;8(49):86253-86263. doi: 10.18632/oncotarget.21134. eCollection 2017 Oct 17.
8
Origin of circulating free DNA in patients with lung cancer.肺癌患者循环游离 DNA 的来源。
PLoS One. 2020 Jul 7;15(7):e0235611. doi: 10.1371/journal.pone.0235611. eCollection 2020.
9
The size of cell-free mitochondrial DNA in blood is inversely correlated with tumor burden in cancer patients.癌症患者血液中游离线粒体DNA的大小与肿瘤负荷呈负相关。
Precis Clin Med. 2019 Sep;2(3):131-139. doi: 10.1093/pcmedi/pbz014. Epub 2019 Oct 1.
10
Design of a Targeted Sequencing Assay to Detect Rare Mutations in Circulating Tumor DNA.用于检测循环肿瘤DNA中罕见突变的靶向测序分析方法的设计
Genet Test Mol Biomarkers. 2019 Apr;23(4):264-269. doi: 10.1089/gtmb.2018.0173.

引用本文的文献

1
Performance of KRAS mutation detection in plasma exosomes from patients with early-stage colorectal cancer.早期结直肠癌患者血浆外泌体中KRAS基因突变检测的性能
J Transl Med. 2025 Jul 2;23(1):730. doi: 10.1186/s12967-025-06710-0.
2
Predicting high confidence ctDNA somatic variants with ensemble machine learning models.使用集成机器学习模型预测高置信度的ctDNA体细胞变异
Sci Rep. 2025 May 26;15(1):18384. doi: 10.1038/s41598-025-01326-2.
3
Liquid Biopsy in the Clinical Management of Cancers.液体活检在癌症临床管理中的应用。

本文引用的文献

1
Enhanced detection of circulating tumor DNA by fragment size analysis.通过片段大小分析增强循环肿瘤 DNA 的检测。
Sci Transl Med. 2018 Nov 7;10(466). doi: 10.1126/scitranslmed.aat4921.
2
Automated size selection for short cell-free DNA fragments enriches for circulating tumor DNA and improves error correction during next generation sequencing.自动化选择短细胞游离 DNA 片段可富集循环肿瘤 DNA,并改善下一代测序过程中的错误校正。
PLoS One. 2018 Jul 25;13(7):e0197333. doi: 10.1371/journal.pone.0197333. eCollection 2018.
3
Single-Cell Map of Diverse Immune Phenotypes in the Breast Tumor Microenvironment.
Int J Mol Sci. 2024 Aug 6;25(16):8594. doi: 10.3390/ijms25168594.
4
Impact of ramucirumab plus erlotinib on circulating cell-free DNA from patients with untreated metastatic non-small cell lung cancer with -activating mutations (RELAY phase 3 randomized study).雷莫西尤单抗联合厄洛替尼对未经治疗的具有表皮生长因子受体激活突变的转移性非小细胞肺癌患者循环游离DNA的影响(RELAY 3期随机研究)
Transl Lung Cancer Res. 2023 Aug 30;12(8):1702-1716. doi: 10.21037/tlcr-22-736. Epub 2023 Aug 10.
5
Multimodal analysis of genome-wide methylation, copy number aberrations, and end motif signatures enhances detection of early-stage breast cancer.全基因组甲基化、拷贝数畸变和末端基序特征的多模态分析可提高早期乳腺癌的检测率。
Front Oncol. 2023 May 8;13:1127086. doi: 10.3389/fonc.2023.1127086. eCollection 2023.
6
RCCC_Pred: A Novel Method for Sequence-Based Identification of Renal Clear Cell Carcinoma Genes through DNA Mutations and a Blend of Features.RCCC_Pred:一种通过DNA突变和特征融合基于序列鉴定肾透明细胞癌基因的新方法。
Diagnostics (Basel). 2022 Dec 3;12(12):3036. doi: 10.3390/diagnostics12123036.
7
Improvements in Quality Control and Library Preparation for Targeted Sequencing Allowed Detection of Potentially Pathogenic Alterations in Circulating Cell-Free DNA Derived from Plasma of Brain Tumor Patients.靶向测序的质量控制和文库制备的改进使得能够检测脑肿瘤患者血浆来源的循环游离DNA中潜在的致病性改变。
Cancers (Basel). 2022 Aug 12;14(16):3902. doi: 10.3390/cancers14163902.
8
A Computational Framework to Identify Biomarkers for Glioma Recurrence and Potential Drugs Targeting Them.一种用于识别胶质瘤复发生物标志物及靶向这些标志物的潜在药物的计算框架。
Front Genet. 2022 Jan 17;12:832627. doi: 10.3389/fgene.2021.832627. eCollection 2021.
9
Evaluation of the MGISEQ-2000 Sequencing Platform for Illumina Target Capture Sequencing Libraries.用于Illumina靶向捕获测序文库的MGISEQ-2000测序平台评估
Front Genet. 2021 Oct 27;12:730519. doi: 10.3389/fgene.2021.730519. eCollection 2021.
10
Leveraging the Fragment Length of Circulating Tumour DNA to Improve Molecular Profiling of Solid Tumour Malignancies with Next-Generation Sequencing: A Pathway to Advanced Non-invasive Diagnostics in Precision Oncology?利用循环肿瘤 DNA 的片段长度,通过下一代测序提高实体瘤恶性肿瘤的分子谱分析:精准肿瘤学中先进的非侵入性诊断的途径?
Mol Diagn Ther. 2021 Jul;25(4):389-408. doi: 10.1007/s40291-021-00534-6. Epub 2021 May 20.
乳腺肿瘤微环境中多样化免疫表型的单细胞图谱
Cell. 2018 Aug 23;174(5):1293-1308.e36. doi: 10.1016/j.cell.2018.05.060. Epub 2018 Jun 28.
4
Size-tagged preferred ends in maternal plasma DNA shed light on the production mechanism and show utility in noninvasive prenatal testing.大小标记的母体外周血游离 DNA 偏好末端揭示了其产生机制,并在无创产前检测中具有实用价值。
Proc Natl Acad Sci U S A. 2018 May 29;115(22):E5106-E5114. doi: 10.1073/pnas.1804134115. Epub 2018 May 14.
5
Circulating Tumor DNA: Measurement and Clinical Utility.循环肿瘤 DNA:检测与临床应用
Annu Rev Med. 2018 Jan 29;69:223-234. doi: 10.1146/annurev-med-041316-085721. Epub 2017 Aug 28.
6
Integrating liquid biopsies into the management of cancer.将液体活检纳入癌症管理中。
Nat Rev Clin Oncol. 2017 Sep;14(9):531-548. doi: 10.1038/nrclinonc.2017.14. Epub 2017 Mar 2.
7
Liquid biopsies come of age: towards implementation of circulating tumour DNA.液体活检时代的到来:迈向循环肿瘤 DNA 的临床应用。
Nat Rev Cancer. 2017 Apr;17(4):223-238. doi: 10.1038/nrc.2017.7. Epub 2017 Feb 24.
8
Liquid Biopsies, What We Do Not Know (Yet).液体活检,未解之谜。
Cancer Cell. 2017 Feb 13;31(2):172-179. doi: 10.1016/j.ccell.2017.01.002.
9
Fragment Length of Circulating Tumor DNA.循环肿瘤DNA的片段长度
PLoS Genet. 2016 Jul 18;12(7):e1006162. doi: 10.1371/journal.pgen.1006162. eCollection 2016 Jul.
10
Origins, structures, and functions of circulating DNA in oncology.肿瘤学中循环DNA的起源、结构及功能
Cancer Metastasis Rev. 2016 Sep;35(3):347-76. doi: 10.1007/s10555-016-9629-x.